This would follow that because a significant percentage of breast cancer have p53 mutations, it is reasonable to posit that patients with bladder cancer as an index cancer that is also associated with p53 mutation on the same allele would have an increased incidence of breast cancer as a second primary malignancy. The gene discussed is TP53; the disease is breast carcinoma.